An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1.
Jeimy
S B
SB
Krakow
E F
EF
Fuller
N
N
Tasneem
S
S
Hayward
C P M
CP
D000369:Aged, 80 and over; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D001798:Blood Proteins / Q000378:metabolism*; D003131:Combined Modality Therapy; D004705:Endocytosis; D005165:Factor V / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D005166:Factor V Deficiency / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D015943:Factor Va / Q000378:metabolism; D017809:Fatal Outcome; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D011485:Protein Binding; D013917:Thrombin / Q000096:biosynthesis
D001323:Autoantibodies; D001798:Blood Proteins; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; C069282:multimerin; D015943:Factor Va; D005165:Factor V; D013917:Thrombin